We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
On 8 and 9 October 2020, the Therapeutic Goods Administration (TGA) hosted three webinar information sessions to explain the interim decision on nicotine with an opportunity for questions and answers (Q&A).
Disclaimer
These presentation papers are provided on the TGA's website solely for the purpose of indicating or suggesting what TGA representatives spoke about to the various conferences and seminars to which it relates. The papers are not legislative in nature and should not be taken to be statements of any law or policy in any way.
The Australian Government Department of Health (of which the TGA is a part) advises that (a) the presentation papers should not be relied upon in any way as representing a comprehensive description of regulatory requirements, and (b) cannot guarantee, and assumes no legal liability or responsibility for, the accuracy, currency or completeness of the information contained in the presentation paper.
Presentation
- Presented by: Adj. Prof John Skerritt, Ms Jenny Francis, Mr Avi Rebera
- Presented at: Online
- Presentation date: Thursday 8 October 2020
- Presentation summary: Information session for consumers and health practitioners on proposed changes to the way nicotine is supplied
- The presentation slides are available at: Information Webinar: Proposed changes to the way nicotine is supplied
Recording of online Q&A, Thursday 8 October 2020
Transcript
The transcript will be available soon. If you need assistance in the meantime, please contact us.